Gary Jacobson Named Executive Vice President and Chief Financial Officer at Ricerca...

* Reuters is not responsible for the content in this press release.

Tue Sep 2, 2008 3:43pm EDT

Gary Jacobson Named Executive Vice President and Chief Financial Officer at Ricerca Biosciences

CONCORD, Ohio--(Business Wire)--
Ricerca Biosciences, a uniquely integrated preclinical provider of
contract research services for the pharmaceutical industry has named
Gary Jacobson executive vice president and chief financial officer. In
addition to his financial responsibilities, he will be accountable for
Ricerca's legal, human resources, facilities and IT functions.

   "I'm delighted to welcome Gary to Ricerca," said Ricerca Chairman
& CEO, R. Ian Lennox. "Gary will further strengthen Ricerca's
management team and provide valuable capabilities for our continued
successful growth."

   Prior to joining Ricerca, Jacobson was principal and director of
General Biotechnology, LLC. He served as executive vice president and
chief financial officer of Harlan Sprague Dawley, Inc. and chief
operating officer of Harlan Europe. Gary began his career in the
banking industry serving as senior vice president and division manager
of LaSalle National Bank and senior vice president of American
National Bank.

   Jacobson is a graduate of Knox College in Galesburg, IL, and holds
a certificate in political economy from the Adam Smith School of
Economics in Glasgow, Scotland. He received his MBA from Marshall
University in Huntington, WV.

   About Ricerca Biosciences

   Ricerca is the only North American CRO that takes pharmaceutical
and biotech companies straight through from IP to IND. Our
state-of-the-art facility combined with over 300 scientists and
support staff provides all of the discovery and development services
required to bring target or drug candidates to complete IND
submission. Ricerca's unique ability to seamlessly integrate chemistry
and biology, along with report writing and regulatory services at one
location, allows companies to achieve their preclinical
destination--faster and without any detours.

Ricerca Biosciences
Wendy Rich, 440-357-3607
Rich_w@ricerca.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.